Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-18
DOI
10.1186/s13287-020-01875-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia
- (2020) Kunhua Li et al. INVESTIGATIVE RADIOLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
- (2020) Linyu Geng et al. Frontiers in Immunology
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China
- (2020) Jianlei Cao et al. CLINICAL INFECTIOUS DISEASES
- Diabetes is a risk factor for the progression and prognosis of COVID-19
- (2020) Weina Guo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical course and mortality risk of severe COVID-19
- (2020) Paul Weiss et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Mesenchymal stem/stromal cell function in modulating cell death
- (2019) Abderrahim Naji et al. Stem Cell Research & Therapy
- Impact of Graphene-Based Surfaces on the Basic Biological Properties of Human Umbilical Cord Mesenchymal Stem Cells: Implications for Ex Vivo Cell Expansion Aimed at Tissue Repair
- (2019) Joanna Jagiełło et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity
- (2019) Karla Schoen et al. BMC INFECTIOUS DISEASES
- Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
- (2019) Yeming Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial
- (2018) Lauralyn A. McIntyre et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord
- (2018) Mingjun Wu et al. Scientific Reports
- Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus–Associated Acute Lung Injury
- (2018) Hayley Loy et al. JOURNAL OF INFECTIOUS DISEASES
- Cell Death in the Lung: The Apoptosis–Necroptosis Axis
- (2018) Maor Sauler et al. Annual Review of Physiology
- The hUC-MSCs cell line CCRC-1 represents a novel, safe and high-yielding HDCs for the production of human viral vaccines
- (2017) Ping Chen et al. Scientific Reports
- Mesenchymal Stromal Cells are Readily Recoverable from Lung Tissue, but not the Alveolar Space, in Healthy Humans
- (2016) K. A. Sinclair et al. STEM CELLS
- Rationale for Determining the Functional Potency of Mesenchymal Stem Cells in Preventing Regulated Cell Death for Therapeutic Use
- (2016) Abderrahim Naji et al. Stem Cells Translational Medicine
- Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion
- (2015) Jinquan Cai et al. DIABETES CARE
- Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy
- (2015) Tan Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
- (2014) Per-Ola Carlsson et al. DIABETES
- Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
- (2014) Guoping Zheng et al. RESPIRATORY RESEARCH
- A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus
- (2014) Xuebin Liu et al. Stem Cell Research & Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started